Wells Fargo’s Evolus EOLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-82,700
Closed -$8K 6978
2020
Q4
$8K Buy
+82,700
New +$310K ﹤0.01% 6060
2020
Q3
Sell
-15,000
Closed -$14K 6448
2020
Q2
$14K Buy
+15,000
New +$69.1K ﹤0.01% 5776
2020
Q1
Sell
-60,600
Closed -$1K 6333
2019
Q4
$1K Buy
+60,600
New +$855K ﹤0.01% 6242

Other funds holding EOLS

Wells Fargo's EOLS Position: Q1 2026 in Review

Wells Fargo reduced its Evolus (EOLS) stake by 1.9% in Q1 2026, selling an estimated $7.13K and leaving 74,497 shares worth $306K. The position accounts for ﹤0.01% of the portfolio, ranked #4435.

Wells Fargo first reported a position in EOLS in Q1 2018 and has held it in 33 quarters since. The position peaked at $717K in Q1 2019. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • Wells Fargo held 74,497 shares of Evolus worth $306K as of Q1 2026.
  • Wells Fargo sold 1,471 Evolus shares in Q1 2026, an estimated $7.13K.
  • Evolus made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4435 holding.
  • Wells Fargo first reported a position in Evolus in Q1 2018 and has held it in 33 quarters since.
  • Wells Fargo's Evolus position peaked at $717K in Q1 2019.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.